Tempus AI TEM Strategic Positioning Amidst Operating Challenges Creates Attractive Entry Point Pebblebrook PEB Stock Entry Strategy Institutional Selling 20260415 Esquire ESQ Stock Outlook Esquire Financial Holdings notches 03 EPS beat AIT Applied Ind Q1 earnings nearly meet forecasts but miss by 09 sending shares down 05 Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues Merchants Bancorp MBIN Q1 2026 Earnings EPS Beats Expectations by 5 Stock Slightly Lower LCID Q1 2026 Earnings EPS Miss Widens Amid Revenue Visibility Challenges ODD Q4 2025 Earnings EPS Surges Past Estimates as Profitability Improves YUMC Q1 2026 Earnings EPS Miss and Cautious Outlook Weigh on Shares Praxis Precision Medicines Inc PRAX Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue